Application no. and date | 14172991.3 (espacenet) (Federated) (European Patent Register), 20110325 | Patent/reg. no. and date | DK/EP 2826776, 20201125 | Publication date | 20150121 | Priority no. and date | US 317376 P, 20100325, US 319953 P, 20100401, US 321636 P, 20100407, US 321561 P, 20100407 | EP pub. no. and date |
EP 2826776 20150121 | Effective date | | Applicant/owner | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | Applicant ref. no. | P74906DK01 | Inventor | KRAWIEC, Mariusz, 46 Littlefield Lane
Marlborough, MA 01752, US, ZHANG, Yuegang, 15 Fairfield Road
Wayland, MA 01778, US, ZHANG, Beili, 4505 Shorepointe Way
San Diego, CA 92130, US, KESHAVARZ-SHOKRI, Ali, 4285 Corte Langostino
San Diego, CA 92130, US, Lee, Elaine Chungmin, 303 Third Street, Apt. 16,
Cambridge, MA 02142, US, Alcacio, Tim Edward, 9174 Huntington Ave
San Diego, CA 92123, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/404 (2006.01) , A61K 9/10 (2006.01) , A61P 11/00 (2006.01) , C07D 405/12 (2006.01) | Title | FAST DISPERSION AF AMORF FORM AF (R)-1(2,2-DIFLUORBENZO(D)(1,3)DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUOR-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)-CYCLOPROPANCARBOXAMID | Int. application no. | | Int. publication no. | | Related patent (certificate) | CA 2021 00013 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|